Clinical Trial: 6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07146451) titled '6-year Outcomes in Children After Nifedipine vs Placebo for Preterm Prelabor Rupture of Membranes at 22-33 Weeks' on July 16.

Brief Summary: The purpose of this study is to evaluate the neurodevelopment at age 6 of children born to women with preterm prelabor rupture of membranes at 22 to 33 weeks of gestation, after antenatal exposure to nifedipine vs placebo.

Study Start Date: Oct., 2025

Study Type: OBSERVATIONAL

Condition: Children Born to Mothers Enrolled in the TOCOPROM Trial

Intervention: OTHER: Self-administered parental questionnaire

A self-administered parental questionnaire, completed online or on paper, to assess d...